oxymatrine has been researched along with Chronic Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, GD; Ma, P; Wang, Y; Xiong, AQ; Xu, QB; Xu, YH; Yuan, YN; Zheng, P | 1 |
| Chen, Y; Fang, YN; Guo, CY; Li, Q; Wang, Y | 1 |
| Ao, HH; Bai, J; Hu, ST; Shen, YF; Tang, Y; Wang, YL; Yang, YJ | 1 |
| Dai, XY; Hao, YJ; Li, YX; Liu, HY; Sun, T; Wang, HY; Yu, JQ | 1 |
| Cai, X; Chen, CW; Chen, WX; Fu, QC; Li, CZ; Lu, LG; Mao, YM; She, WM; Tang, MF; Wan, MB; Wang, H; Wang, JY; Wu, SM; Ye, J; Zeng, MD; Zhang, HQ; Zhou, XQ; Zhu, JS | 1 |
| Chen, C; Jin, Y | 1 |
1 trial(s) available for oxymatrine and Chronic Disease
| Article | Year |
|---|---|
Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Alkaloids; Antiviral Agents; Biomarkers; Capsules; Chronic Disease; Double-Blind Method; Female; Hepatitis, Viral, Human; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Placebos; Quinolizines; Treatment Outcome | 2004 |
5 other study(ies) available for oxymatrine and Chronic Disease
| Article | Year |
|---|---|
[Protective effect of oxymatrine on chronic heart failure and ADMA metabolism pathway in isoproterenol-induced chronic heart failure in rats].
Topics: Alkaloids; Amidohydrolases; Animals; Arginine; Chronic Disease; Gene Expression Regulation, Enzymologic; Heart Failure; Hemodynamics; Isoproterenol; Male; Organ Size; Quinolizines; Rats; Rats, Sprague-Dawley; Troponin I | 2014 |
[Antifibrotic effects of oxymatrine in mice with chronic viral myocarditis].
Topics: Alkaloids; Animals; Antiviral Agents; Captopril; Chronic Disease; Disease Models, Animal; Down-Regulation; Enterovirus B, Human; Fibrosis; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Quinolizines; Transforming Growth Factor beta1; Virus Diseases | 2010 |
Protective effect of oxymatrine on chronic rat heart failure.
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Calcium; Calcium Channels, L-Type; Calcium Signaling; Chronic Disease; Heart Failure; Male; Mitochondria, Heart; Quinolizines; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2011 |
Effects of oxymatrine on the neuropathic pain induced by chronic constriction injury in mice.
Topics: Alkaloids; Animals; Chronic Disease; Constriction; Disease Models, Animal; Dose-Response Relationship, Drug; GABA Antagonists; GABA Plasma Membrane Transport Proteins; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Gene Expression Regulation; Male; Mice; Mice, Inbred ICR; Muscimol; Neuralgia; Neuroprotective Agents; Nipecotic Acids; Oximes; Pain Measurement; Pain Threshold; Quinolizines; Receptors, GABA-A; Spinal Cord | 2012 |
[Effects of oxymatrine on expression of nuclear factor kappa B in kidneys of rats with adriamycin-induced chronic renal fibrosis].
Topics: Alkaloids; Animals; Chronic Disease; Doxorubicin; Fibrosis; I-kappa B Proteins; Immunohistochemistry; Kidney; Male; NF-kappa B; Quinolizines; Random Allocation; Rats; Rats, Wistar | 2007 |